When using retrospective data, what is a key consideration for IRB review regarding consent?

When using retrospective data, what is a key consideration for IRB review regarding consent?

• A. Whether data is anonymized after publication.
• B. Whether participants enjoyed the initial study.
• C. Whether consent for secondary use is available or a waiver can be justified.
• D. Whether consent for secondary use is available or a waiver can be justified.

Answer: (D)

When researchers use retrospective data, the IRB must determine whether there is existing consent for the secondary use of that data or whether a waiver of consent can be justified. This matters because secondary analyses can proceed only if the participants’ autonomy is respected either through prior consent or through a justified waiver under regulatory criteria. A waiver is appropriate only if the study involves minimal risk, does not adversely affect participants’ rights and welfare, could not practicably be carried out without the waiver, and includes protections to safeguard privacy and confidentiality. If these conditions are met, the IRB can approve the secondary use without new consent. Other considerations, like whether data are anonymized after publication or whether participants enjoyed the initial study, do not address the consent requirement for secondary use in the same way.

When researchers use retrospective data, the IRB must determine whether there is existing consent for the secondary use of that data or whether a waiver of consent can be justified. This matters because secondary analyses can proceed only if the participants’ autonomy is respected either through prior consent or through a justified waiver under regulatory criteria. A waiver is appropriate only if the study involves minimal risk, does not adversely affect participants’ rights and welfare, could not practicably be carried out without the waiver, and includes protections to safeguard privacy and confidentiality. If these conditions are met, the IRB can approve the secondary use without new consent. Other considerations, like whether data are anonymized after publication or whether participants enjoyed the initial study, do not address the consent requirement for secondary use in the same way.